1. bookVolume 28 (2015): Issue 3 (September 2015)
Journal Details
License
Format
Journal
eISSN
2300-6676
First Published
30 May 2014
Publication timeframe
4 times per year
Languages
English
Open Access

Omentin - a new adipokine with many roles to play

Published Online: 26 Nov 2015
Volume & Issue: Volume 28 (2015) - Issue 3 (September 2015)
Page range: 176 - 180
Received: 15 Jan 2015
Accepted: 15 Sep 2015
Journal Details
License
Format
Journal
eISSN
2300-6676
First Published
30 May 2014
Publication timeframe
4 times per year
Languages
English

1. Akbarzadeh S., Ghasemi S., Kalantarhormozi M., et al.: Relationship among plasma adipokines, insulin and androgens level, as well as biochemical glycemic and lipidemic markers with incidence of PCOS in woman with normal BMI. Gynecol. Endocrinol., 28, 7, 2012.Search in Google Scholar

2. Alcelik A., Tosun M., Ozlu M. F., et al.: Serum levels of omentin in end-stage renal disease patients. Kidney Blood Press. Res., 35, 6, 2012.Search in Google Scholar

3. Bastard J., Maachi M., Lagathu C. et al.: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw., 17, 1, 2006.Search in Google Scholar

4. Bluher M.: Adipose Tissue Dysfunction in Obesity. Exp. Clin. Endocrinol. Diabetes, 117, 6, 2009.10.1055/s-0029-119204419358089Search in Google Scholar

5. Bremer A. A., Jialal I.: Adipose tissue dysfunction in nascent metabolic syndrome. J. Obes., ID 393192, 2013. (Epub)10.1155/2013/393192363869623653857Search in Google Scholar

6. Calle E. E., Thun M. J.: Obesity and cancer. Oncogene, 23, 38, 2004.Search in Google Scholar

7. Choi J. H., Rhee E. J., Kim K. H., et al.: Plasma omentin-1 levels are reduced in non-obese woman with normal glucose tolerance and polycystic ovary syndrome. Eur. J. Endocrinol., 165, 5, 2011.Search in Google Scholar

8. Couillard C., Ruel G., Archer W. R., et al.: Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J. Clin. Endocrinol. Metab., 90, 12, 2005.Search in Google Scholar

9. De Pergola G., Silvestris F.: Obesity as a major risk for cancer. J. Obes., 2013:291546, 2013. (Epub)Search in Google Scholar

10. De Souza Batista C. M., Yang R. Z., Lee M. J. et al.: Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 56, 6, 2007.Search in Google Scholar

11. Fazeli M. S., Dashti H., Akbarzadeh S., et al.: Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine, 62, 1, 2013.Search in Google Scholar

12. Flehmig G., Scholz M., Kloting N. et al.: Identification of Adipokine Clusters Related to Parameters of Fat Mass, Insulin Sensitivity and Inflammation. PLoS One, 9, 6, 2014.Search in Google Scholar

13. Hotamisligil G.S.: Inflammation and metabolic disorders. Nature, 444 (860-867), 2006.10.1038/nature0548517167474Search in Google Scholar

14. Katsi V., Vamvakou G., Lekakis J., et al.: Omentin, Fat and Heart: Classical Music with New Instruments. Heart, Lung and Circulation, 23, 9, 2014.Search in Google Scholar

15. Kloting N., Fasshauer M., Dietrich A. et al.: Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab., 299, 3, 2010.Search in Google Scholar

16. Lehr S., Hartwig S., Sell H.: Adipokines: a treasure trove for discovery of biomarkers for metabolic disorders. Proteomics Clin. Appl., 6, 1-2, 2012.10.1002/prca.20110005222213627Search in Google Scholar

17. Liu R., Wang X., Bu P.: Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res. Clin. Pract., 93, 1, 2011.Search in Google Scholar

18. Luque-Ramirez M., Martinez-Garcia M. A., Montes-Nieto R., et al.: Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum. Reprod., 28, 7, 2013.Search in Google Scholar

19. Mahde A., Shaker M., Al-Mashhadani Z. Study of omentin-1 and other adipokines and hormones in PCOS patient. OMJ, 24, 2, 2009.Search in Google Scholar

20. Moreno-Navarrete J. M., Catalan V., Ortega F. at al.: Circulating omentin concentration increases after weight loss. Nutr. Metab., 7, 27, 2010.Search in Google Scholar

21. Moreno-Navarrete J. M., Ortega F., Castro A. et al.: Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction. Obesity, 19, 8, 2011.Search in Google Scholar

22. Oświęcimska J., Suwała A., Świętochowska E. et al.: Serum omentin levels in adolescent girls with anorexia nervosa and obesity. Physiol. Res., 2015. (Epub)10.33549/physiolres.93284125804090Search in Google Scholar

23. Otake S., Takeda H., Fujishima S., et al.: Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J. Gastroenterol., 16, 10, 2010.Search in Google Scholar

24. Pan H. Y., Guo L., Li Q.: Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res. Clin. Pract., 88, 1, 2010.Search in Google Scholar

25. Ridker P. M., Buring J. E., Cook N. R., et al.: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation, 107, 3, 2003.Search in Google Scholar

26. Schaffler A., Neumeier M., Herfarth H., et al.: Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim. Biophys. Acta, 1732, 1-3, 2005.10.1016/j.bbaexp.2005.11.00516386808Search in Google Scholar

27. Schaffler A., Zeitoun M., Wobser H. et al.: Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in humangene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel disease. Cardiovasc. Diabetol., 6, 3, 2007.Search in Google Scholar

28. Senolt L., Polanska M., Filkova M. et al.: Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann. Rheum. Dis., 69, doi:10.1136/ ard.2009.119735, 2010.Search in Google Scholar

29. Shetty G. K., Economides P. A., Horton E. S. at al.: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care, 27, 10, 2004.Search in Google Scholar

30. Tan B. K., Adya R., Farhatullah S. et al.: Omentin-1, a novel adipokine, is decreased in overweight insulin resistant woman with the polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes, 57, 4, 2008.Search in Google Scholar

31. Tan B. K., Adya R., Farhatullah S., et al.: Metformin treatment may increase omentin-1 levels in woman with polycystic ovary syndrome. Diabetes, 59, 12, 2010.Search in Google Scholar

32. Tan B. K., Adya R., Randeva H. S.: Omentin: A Novel Link Between Inflammation, Diabesity, and Cardiovascular Disease. TCM, 20, 5, 2010.Search in Google Scholar

33. Tan B. K., Pua S., Syed F., et al.: Decreased plasma omentin-1 levels in Type 1 diabetes mellitus. Diabet. Med., 25, 10, 2008.Search in Google Scholar

34. Thanyasiri P., Celermajer D. S., Adams M. R., et al.: Endothelial dysfunction occurs in peripheral circulation patients with acute and stable coronary artery disease. Am. J. Physiol. Heart Circ. Physiol., 289, 2, 2005.Search in Google Scholar

35. Tonjes A., Fasshauer M., Kratzsch J. et al.: Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes. PLoS One, 5, 11, 2010.Search in Google Scholar

36. Uyeturk U., Sarici H., Tekce B. K. et al.: Serum omentin level in patients with prostate cancer. Med. Oncol., 31, 4, 2014.Search in Google Scholar

37. Van Gall L. F., Mertens I. L., de Block C. E.: Mechanisms linking obesity with cardiovascular disease. Nature, 444 (875-880), 2006.10.1038/nature0548717167476Search in Google Scholar

38. Vu A., Sidhom M. S., Bredbeck B. C., et al.: Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease. Diabetology & Metabolic Syndrome, 6, 4, 2014.Search in Google Scholar

39. Wada J.: Vaspin: A novel serpin with insulin-sensitizing effects. Expert Opin. Inv. Drug, 17, 2008.10.1517/13543784.17.3.32718321232Search in Google Scholar

40. Weisberg S. P., McCann D., Desai M., et al.: Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest., 112, 12, 2003.Search in Google Scholar

41. Xu L., Zhu G. B., Wang L., et al.: Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J. Investing Med., 60, 3, 2012.Search in Google Scholar

42. Yamawaki H. Tsubaki N., Mukohda M. et al.: Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem. Biophys. Res. Commun., 393, 4, 2010.Search in Google Scholar

43. Yamawaki H.: Vascular effects of novel adipokines: focus on vascular contractility and inflammatory responses. Biol. Pharm. Bull., 34, 3, 2011.10.1248/bpb.34.30721372376Search in Google Scholar

44. Yan P., Liu D., Long M., et al.: Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes, 119, 4, 2011.Search in Google Scholar

45. Yang R. Z., Lee M. J. Hu H. et al.: Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab., 290, 6, 2006.Search in Google Scholar

46. Zhang Y.Y., Zou L.M.: Omentin-1, new adipokine, promotes apoptosis through regulating Sirt1-dependant p53 deacetylation in hepatocellular carcinoma cells. Eur. J. Pharmacol., 698, 1-3, 2013.10.1016/j.ejphar.2012.11.01623178529Search in Google Scholar

47. Zheng L., Weng M., Qi M., et al.: Aberrant expression of intelectin-1 in gastric cancer: its relationship with clinicopathological features and prognosis. J. Cancer Res. Clin. Oncol., 138, 1, 2012.Search in Google Scholar

48. Zhong X., Li X., Liu F., et al.: Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NK-κB pathway. Biochem. Biophys. Res. Commun., 425, 2, 2012.Search in Google Scholar

49. Zhong X., Zhang H., Tan H. et al.: Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacologica Sinica, 32, 7, 2011. Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo